Evidence map›Paper›PMID 38152330›Full record

ArticleOpen medicine (Warsaw, Poland)2023

Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes.

Xuefang Liu, Youyan Qiu, Dandan Chen, Jingni Xiong, Biwen Xia, Caiqin Chen, Suyan Li

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xuefang LiuDepartment of Endocrinology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou 511300, Guangdong Province, PR China.
Youyan QiuDepartment of Endocrinology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou 511300, Guangdong Province, PR China.
Dandan ChenDepartment of Endocrinology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou 511300, Guangdong Province, PR China.
Jingni XiongDepartment of Endocrinology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou 511300, Guangdong Province, PR China.
Biwen XiaDepartment of Endocrinology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou 511300, Guangdong Province, PR China.
Caiqin ChenDepartment of Endocrinology, The Fourth Affiliated Hospital of Guangzhou Medical University, No. 1, Guangming East Road, Zengjiang Street, Zengcheng District, Guangzhou 511300, Guangdong Province, PR China.
Suyan LiDepartment of Endocrinology, The Fourth Affiliated Hospital of Guangzhou Medical University, No. 1, Guangming East Road, Zengjiang Street, Zengcheng District, Guangzhou 511300, Guangdong Province, PR China.
Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association of thyroid hormone antibodies and glycolipid metabolism indicators with Type 2 diabetes mellitus (T2DM) was explored. As the disease worsens, the levels of thyroglobulin antibody (TGAb), thyroid peroxidase antibody (TPOAb), and thyroid-stimulating hormone (TSH) was increased, and the levels of total tri-iodothyronine (TT3) and total thyroxine (TT4) was decreased (

Indexed as

antibodies to glucose and lipid metabolismmonitoring valuequality of lifethyroid hormonetype 2 diabetes

Identifiers

PMID38152330
PMCPMC10751898
OpenAlexW4390017571

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.